ACCENDRA HEALTH INC/VA/ 8-K

What Happened
Accendra Health, Inc. announced the expiration and the final results of its Exchange Offers and Consent Solicitations and filed an 8-K on June 25, 2026 that incorporates a June 23, 2026 press release (Exhibit 99.1). The filing also references the Explanatory Note regarding the final settlement of the Exchange Offers.

Key Details

• The company issued a press release dated June 23, 2026 announcing the expiration and final results; that press release is filed as Exhibit 99.1 to the 8-K.
• The June 25, 2026 8-K incorporates the Explanatory Note concerning the final settlement of the Exchange Offers.
• The report was signed by Jonathan A. Leon, Executive Vice President and Chief Financial Officer of Accendra Health.

Why It Matters
Exchange offers and consent solicitations relate to the company’s securities and creditor arrangements; the filing provides official notice that these actions have completed and that final settlement details are recorded. Investors should review the referenced press release and Explanatory Note (Exhibit 99.1) for specifics on how the offers affect outstanding securities, creditor rights, or the company’s capital structure.